This week, nine medical devices stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Winner Medical Group (WWIN) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
This week, Novadaq Technologies’ (NVDQ) ratings are up from a B last week to an A. Novadaq Technologies develops and commercializes medical devices based on its proprietary imaging platform for the diagnosis and treatment of human vascular and opthalmic diseases and conditions. Shares of the stock have been trading at an exceptionally rapid pace, up twofold from the week prior. For more information, get Portfolio Grader’s complete analysis of NVDQ stock.
LeMaitre Vascular, Inc. (LMAT) shows solid improvement this week. The company’s rating rises from a B to an A. LeMaitre Vascular manufactures medical devices for vascular surgeons and interventionists. For more information, get Portfolio Grader’s complete analysis of LMAT stock.
This week, Globus Medical, Inc. Class A (GMED) pushes up from a B to an A rating. Globus Medical focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. The stock price has risen 14.4% over the past month, better than the 1.7% decrease the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of GMED stock.
IDEXX Laboratories, Inc. (IDXX) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. Idexx Laboratories provides diagnostic, detection, and information systems for veterinary, food, and water testing applications. Wall Street has pushed the stock higher by 7.8% over the past month. For more information, get Portfolio Grader’s complete analysis of IDXX stock.
This is a strong week for CryoLife, Inc. (CRY). The company’s rating climbs to A from the previous week’s B. CryoLife preserves and distributes human tissues in addition to developing, manufacturing, and commercializing medical devices for cardiac and vascular transplant applications. Shares of the stock have been changing hands at an unusually rapid pace, twice the rate of the week prior. For more information, get Portfolio Grader’s complete analysis of CRY stock.
Unilife Corporation (UNIS) gets a higher grade this week, advancing from a C last week to a B. Unilife Medical Solutions specializes in the design, development and supply of safety medical devices. For more information, get Portfolio Grader’s complete analysis of UNIS stock.
Utah Medical Products, Inc. (UTMD) shows solid improvement this week. The company’s rating rises from a C to a B. Utah Medical Products produces and markets medical devices for the healthcare industry. For more information, get Portfolio Grader’s complete analysis of UTMD stock.
Cyberonics, Inc. (CYBX) boosts its rating from a C to a B this week. Cyberonics is a neuromodulation company that designs, develops, sells, and markets implantable medical devices to be used in the treatment of refractory epilepsy and treatment-resistant depression. Wall Street seems to agree with the upgrade and has propelled the stock up 7.2% over the past month. For more information, get Portfolio Grader’s complete analysis of CYBX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
